Erschienen in:
01.09.2015 | Editorial
Early goal-directed therapy: from discovery through enthusiasm to equipoise?
verfasst von:
James A. Russell, Morten Hylander Møller, Djillali Annane
Erschienen in:
Intensive Care Medicine
|
Ausgabe 9/2015
Einloggen, um Zugang zu erhalten
Excerpt
The original Rivers trial [
1] of early goal-directed therapy (EGDT) discovered that a process of EGDT that guided fluids, vasopressors, inotropic agents and transfusions in the first 6 h of sepsis dramatically reduced mortality (relative risk reduction, RRR of 42 %) compared to usual care in an emergency department (ED) setting. That discovery ushered in an exciting era of early identification, resuscitation and monitoring of patients with sepsis. Since 2003, EGDT has been recommended in international sepsis guidelines [
2‐
4], and implementation in routine care has been associated with benefits [
5]. Likewise, many observers suggested that prompt recognition and treatment of sepsis may partly explain declining mortality from sepsis [
6,
7]. …